Effect of Nursing Intervention on Treatment Burden and Self-management Among Adolescents With Thalassemia
Effect of an Orem's Self-care Theory -Based Nursing Intervention on Treatment Burden and Self-management Among Adolescents With Thalassemia
This study aims to evaluate the effect of a nursing intervention based on Orem's self-care theory on treatment burden and self-management among adolescents diagnosed with thalassemia. Adolescents with thalassemia face significant physical and psychosocial challenges that affect their daily routines and treatment adherence. The intervention consists of educational and supportive sessions designed to enhance self-care agency and reduce treatment burden. Participants will be evaluated before and after the implementation of the nursing program to measure changes in treatment burden and self-management behaviors.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Abbas O Mijbas
- Phone Number: 07811038519 009647811038519
- Email: abbas.obaid2504m@conursing.uobaghdad.edu.iq
Study Locations
-
-
Babylon
-
Hillah, Babylon, Iraq, 51001
- Thalasemmia centers
-
Contact:
- Abbas O Mijbas
- Phone Number: 07811038519
- Email: abbas.obaid2504m@conursing.uobaghdad.edu.iq
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adolescents aged 12-18 years.
- diagnosed with β-thalassemia major/transfusion-dependent β-thalassemia by a physician.
- Receiving regular blood transfusion therapy according to their treatment plan.
- Receiving regular iron chelation therapy.
- Able to communication and understanding sufficiently to complete in intervention.
- Willing to participate in the study with written informed assent from the adolescent and informed consent from the parent/ legal guardian.
Exclusion Criteria:
- adolescents with sever medical complication.
- adolescents with sever cognitive, intellectual, or developmental impairment that prevent understanding or participation in study.
- participants who have undergone or currently undergoing hematopoietic stem cell transplantation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control group
|
|
|
Experimental: Intervention group
|
A structured educational and supportive nursing program based on Orem's self-care theory, designed to enhance self-care agency, improve disease self-management, and reduce treatment burden among adolescents with thalassemia |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-management
Time Frame: 8 weeks
|
Mean Score of Self-Management Measured by the Self-management and transition to adulthood with Rx (STARx). Self-management behaviors will be assessed using a validated Self-Management Questionnaire. The total score ranges from [0] to [90], where higher scores indicate better self-management practices. Baseline (pre-intervention) and 8 weeks post-intervention |
8 weeks
|
|
Treatment Burden
Time Frame: 8 weeks
|
Treatment burden will be evaluated using the validated The Medication-Related Burden Quality of Life (MRB-QoL) . The total score ranges from [31] to [155], where higher scores indicate a greater perceived burden of treatment Baseline (pre-intervention) and 8 weeks post-intervention |
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Asmahan Q Mohammed, University of Baghdad
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Mijbas-2026-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.